MMP inhibitors are pharmaceutical agents designed to block the activity of matrix metalloproteinase enzymes, which are responsible for the breakdown of extracellular matrix proteins. These compounds are… Read more





MMP inhibitors are pharmaceutical agents designed to block the activity of matrix metalloproteinase enzymes, which are responsible for the breakdown of extracellular matrix proteins. These compounds are investigated for their potential in treating various conditions, including cancer metastasis, arthritis, and cardiovascular diseases. This category provides essential reference standards, including active inhibitors and their related impurities, for use in pharmaceutical research and quality control. Analytical laboratories utilize these materials for impurity profiling, method validation, and the development of sensitive assays to accurately quantify degradation products during synthesis and manufacturing. By supplying high-quality reference materials for specific targets such as MMP-2, MMP-3, MMP-8, and MMP-9, this collection supports the rigorous testing required to ensure the stability, safety, and efficacy of potential therapeutic compounds throughout the drug development lifecycle.